Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.

A national shortage in a common treatment for attention-deficit hyperactivity disorder was associated with changes in stimulant prescriptions filled for children over recent years, a new study ...

This includes findings on differences in long covid between adults and kids.But Davids said the NIH shouldn ... said she’s ...

Four in 10 Minnesotans who contracted COVID-19 reported in a new state survey that they struggled with lingering health ...

Adderall shortages have prompted doctors to switch kids with attention-deficit/hyperactivity disorder to other forms of ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

Cancer deaths overall are falling, but the burden is shifting toward younger adults and women, the American Cancer Society ...

Health bodies have highlighted six key symptoms of a lesser-known illness that has no vaccine amid a spike in cases in the UK ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...